Why Covid is still flooring some people
A lot of us know someone who has felt pretty rough with the most recent form of the virus.
Similar Posts
Finding happiness after the Clutha helicopter crash
It’s a decade since a police helicopter crashed through the roof of the Clutha Bar in Glasgow. Among those there that Friday night was Michael Byrne. He helped pull survivors from the rubble at the city centre bar, where 10 people lost their lives. Although Michael managed to escape without injury, the emotional impact the…
Obesity and Alzheimer’s drugs pack one-two punch to lift Eli Lilly
Investor optimism for Eli Lilly ‘s diabetes and obesity treatments in 2023 lifted the stock to its seventh annual gain in a row. In the new year, it should be the same old story. Shares of Eli Lilly have taken a breather over the past three months, as investors book profits in the top performer…
Renewed interest in ADCs will continue in 2024
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead….
Respiratory illnesses remain ‘elevated’ throughout much of country: CDC
Join Fox News for access to this content Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the…
J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B
An entry sign to the Johnson & Johnson campus shows their logo in Irvine, California on August 28, 2019. Mark Ralston | AFP | Getty Images Johnson & Johnson on Monday said it will pay $2 billion in cash to acquire Ambrx Biopharma, a drugmaker specializing in one of the hottest areas of cancer treatment….
Decoding Dietary Fats: The Good, The Bad, and The Strategy for Healthy Eating
In the realm of nutrition, fat has long been a topic of contentious debate. Once vilified as the root cause of obesity and heart disease, modern research has nuanced our understanding, distinguishing between “good” and “bad” fats. This differentiation is crucial for making informed dietary choices that support overall health and well-being. This blog post…